Lewis H. Titterton Jr., Anixa Biosciences stock purchase

Director, SEC Form 4, filed on September 14, 2026
$27,30010,000 shares, average $2.73
Transaction date
September 10, 2026
Shares held after
996,967Direct ownership
Change in holding
+1.01%From the transactions in the filing
Filing rows
1All open market

Price context

ANIX daily close, Apr 27 to October 26, 2026
$3.75$2.35
Daily close
Purchase
Trade average $2.73
Transaction price
$2.73Weighted average
Close on trade date
$2.75September 10, 2026
Latest close
$2.93October 26, 2026
Since the trade
+7.33%vs the trade average

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Purchase
Common stockDirect
10,000
$2.73
$27,300
996,967

Recent filings at Anixa Biosciences

Full history
PersonTransactionAmount or sharesDate
Lewis H. Titterton Jr.Director
Purchase
$23,840
Amit KumarCEO
Purchase
$21,760
Michael CatelaniCFO
Purchase
$15,620
Amit KumarCEO
Purchase
$19,460
Arnold M. BaskiesDirector
Purchase
$13,800
Amit KumarCEO
Purchase
$13,800
Amit KumarCEO
Purchase
$8,250
Amit KumarCEO
Purchase
$17,350